Anna Fang Overview
- Firm
- ZhenFund
- Primary Position
-
Founding Partner...
- Primary Industry
-
Information Technology
- Active Board Seats
-
2
- Med. Deal Size
-
- Med. Valuation
-
Anna Fang General Information
Biography
Ms. Anna Fang is a Founding Partner & serves as Chief Executive Officer at ZhenFund. She serves as a Board Member of Nomisma. She oversees the fund's investments, portfolio management and operations. Her investments include RED (Xiaohongshu), VIPKID, Mia, Yitu Technology, Mobvoi, Club Factory, ZaoZuo, Perfect Diary, Deep Glint and Horizon Robotics. Prior to ZhenFund, she worked at GE China in Corporate Business Development. She started her career as an investment banker at JPMorgan New York office. She was named a Young Global Leader (YGL) by the World Economic Forum in 2016 and "Early Stage Investor of the Year" in 2016 by Zero2IPO Group. She was also selected onto the Forbes' Midas Brink List in 2016. She received her undergraduate degree from Columbia University in Economics and her MBA from Stanford Graduate School of Business. Anna started her career as an investment banker at JPMorgan in the Consumer Healthcare Retail Group. She later joined GE China's Corporate Business Development team helping to expand the company's M&A and BD efforts in China before joining ZhenFund in 2011. Anna received an undergraduate degree from Columbia University in Economics and a Master's degree in Business Administration from Stanford's Graduate School of Business. She is currently an advisory board member of Columbia College and Columbia's Global Centers; she also leads the Beijing chapter of Stanford GSB.
Contact Information
Address
- Beijing
- China
Anna Fang Positions (1)
Firm name | Firm type | Title | Location | Industry | Since |
---|---|---|---|---|---|
ZhenFund | Investor | Founding Partner & Chief Executive Officer | Beijing, China | Venture Capital |
Anna Fang Board Seats (2)
Company | Industry | Ownership Status | Financing Status | Location | Since |
---|---|---|---|---|---|
MailTime | Communication Software | Privately Held (backing) | Venture Capital-Backed | Hong Kong, Hong Kong | |
Nomisma (Financial Software) | Financial Software | Privately Held (backing) | Venture Capital-Backed | Hong Kong, Hong Kong |
Anna Fang Lead Partner on Deals (10)
Anna Fang has been the lead partner on 10 deals. Their latest deal was with Meliora Therapeutics, a discovery tools (healthcare) company. The deal was made for on 29-Sep-2022.
Company | Deal Date | Deal Type | Deal Size | Deal Status | Industry | Location |
---|---|---|---|---|---|---|
Meliora Therapeutics | 29-Sep-2022 | Seed Round | Completed | Discovery Tools (Healthcare) | Sacramento, CA | |
Shudan Healthcare | 16-May-2022 | Completed | Therapeutic Devices | Hangzhou, China | ||
Shudan Healthcare | 14-Oct-2021 | Completed | Therapeutic Devices | Hangzhou, China | ||
Surreal AI | 30-Aug-2021 | Completed | Automation/Workflow Software | Shenzhen, China | ||
CellX | 20-Aug-2021 | Completed | Food Products | Shanghai, China | ||
X-Times DA | 07-Jun-2021 | Completed | Multimedia and Design Software | Nanjing, China | ||
Surreal AI | 02-Mar-2021 | Completed | Automation/Workflow Software | Shenzhen, China | ||
Nomisma (Financial Software) | 01-May-2018 | Completed | Financial Software | Hong Kong, Hong Kong | ||
Pier (San Francisco) | 15-Aug-2014 | Seed Round | Completed | Consumer Finance | San Francisco, CA | |
MailTime | 28-Jan-2014 | Early Stage VC (Series A) | Completed | Communication Software | Hong Kong, Hong Kong |
Anna Fang Network (29)
Board Members (2)
Name | Company | Representing | Location | From |
---|---|---|---|---|
MailTime | Future Capital Discovery Fund | Hong Kong, Hong Kong | ||
Nomisma (Financial Software) | Nomisma (Financial Software) | Hong Kong, Hong Kong |
Portfolio Executives (26)
Name | Company | Role | Deal date | Location |
---|---|---|---|---|
Leena Young | Meliora Therapeutics | Advisor | 29-Sep-2022 | Sacramento, CA |
Joan Smith | Meliora Therapeutics | Technical Co-Founder | 29-Sep-2022 | Sacramento, CA |
Meliora Therapeutics | Advisor | 29-Sep-2022 | Sacramento, CA | |
Meliora Therapeutics | Scientific Co-Founder | 29-Sep-2022 | Sacramento, CA | |
Meliora Therapeutics | Chief Scientific Officer | 29-Sep-2022 | Sacramento, CA |
Fund Team Members (1)
Name | Investor | Fund | Fund Location |
---|---|---|---|
ZhenFund | Beijing, China |
Anna Fang Affiliated Funds (2)
Fund | Investor | Fund Type | Status | Vintage | Size | Dry Powder | IRR | IRR Quartile |
---|---|---|---|---|---|---|---|---|
ZhenFund RMB Fund VI | ZhenFund | Venture Capital - Early Stage | Closed | 2020 | ||||
Zhen Fund COVI | ZhenFund | Venture - General | Closed | 2021 |
Anna Fang FAQs
-
Who is Anna Fang?
Ms. Anna Fang is a Founding Partner & serves as Chief Executive Officer at ZhenFund.
-
How much does Anna Fang typically invest?
Anna Fang's median deal size is
. -
What is Anna Fang’s main position?
Anna Fang’s primary position is Founding Partner & Chief Executive Officer.
-
What are the contact details for Anna Fang?
Anna Fang’s email address is an
and his phone number is +86 010 . -
How many active board seats does Anna Fang hold?
Anna Fang holds 2 board seats including MailTime and Nomisma (Financial Software).
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »